Polycaprolactone/graphene oxide/acellular matrix nanofibrous scaffolds with antioxidant and promyelinating features for the treatment of peripheral demyelinating diseases.

"Conflict of interest The authors declare no competing interests."

"The authors VA and MN acknowledge the University of New South Wales-Manipal Academy of Higher Education (UNSW-MAHE) collaborative research seed funding. MN would also like to acknowledge the Department of Science & Technology, India for the SERB start-up research grant (SRG/2019/002130) and SERB-POWER research grants (SPG/2021/003703). We also thank Manipal Institute of Regenerative Medicine, MAHE for the infrastructural support. We thank Dr. Shounak De, Associate Professor, Manipal Institute of Technology, India for providing us with the Graphene oxide. The authors acknowledge the facilities and the scientific and technical assistance of Microscopy Australia at the Electron Microscope Unit (EMU) within the Mark Wainwright Analytical Center (MWAC) at UNSW Sydney. The authors acknowledge that the schematic illustrations were created with BioRender.com."